Application of data mining approaches to drug delivery.
暂无分享,去创建一个
[1] R. Ulrich. The toxicogenomics of nuclear receptor agonists. , 2003, Current opinion in chemical biology.
[2] Chris North,et al. Visualizing Biological Pathways: Requirements Analysis, Systems Evaluation and Research Agenda , 2005, Inf. Vis..
[3] Brian K. Shoichet,et al. Virtual screening of chemical libraries , 2004, Nature.
[4] S. Ekins,et al. Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[5] J. Lehmann,et al. Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. , 2002, Molecular pharmacology.
[6] T. Nikolskaya,et al. A COMBINED APPROACH TO DRUG METABOLISM AND TOXICITY ASSESSMENT , 2006, Drug Metabolism and Disposition.
[7] Tatiana Nikolskaya,et al. Early prediction of drug metabolism and toxicity: systems biology approach and modeling. , 2004, Drug discovery today.
[8] Y. Martin,et al. 3D database searching in drug design. , 1992, Journal of medicinal chemistry.
[9] N. Anderson,et al. Proteome and proteomics: New technologies, new concepts, and new words , 1998, Electrophoresis.
[10] Sean Ekins,et al. Computer Applications in Pharmaceutical Research and Development , 2008 .
[11] R. Tongiani,et al. Effects of curcumin on P-glycoprotein in primary cultures of rat hepatocytes. , 1998, Life sciences.
[12] Pravin Chaturvedi,et al. Design principles for orally bioavailable drugs , 1996 .
[13] Sean Ekins,et al. Generation and validation of rapid computational filters for cyp2d6 and cyp3a4. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[14] I. Enyedy,et al. Discovery of a novel dopamine transporter inhibitor, 4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone, as a potential cocaine antagonist through 3D-database pharmacophore searching. Molecular modeling, structure-activity relationships, and behavioral pharmacological studies. , 2000, Journal of medicinal chemistry.
[15] Sean Ekins,et al. A NOVEL METHOD FOR VISUALIZING NUCLEAR HORMONE RECEPTOR NETWORKS RELEVANT TO DRUG METABOLISM , 2005, Drug Metabolism and Disposition.
[16] Kenneth A. Giuliano,et al. High content screening : a powerful approach to systems cell biology and drug discovery , 2007 .
[17] A. Fliri,et al. Biological spectra analysis: Linking biological activity profiles to molecular structure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[18] Philip E. Bourne,et al. Will a Biological Database Be Different from a Biological Journal? , 2005, PLoS Comput. Biol..
[19] Maurizio Fermeglia,et al. Polyamidoamine (Yet Not PAMAM) dendrimers as bioinspired materials for drug delivery: structure-activity relationships by molecular simulations. , 2004, Biomacromolecules.
[20] Chris de Graaf,et al. Cytochrome p450 in silico: an integrative modeling approach. , 2005, Journal of medicinal chemistry.
[21] Peter W. Sprague,et al. CATALYST Pharmacophore Models and Their Utility As Queries for Searching 3D Databases , 2007 .
[22] David Weininger,et al. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..
[23] Sean Ekins,et al. Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity. , 2005, Trends in pharmacological sciences.
[24] K. Chung,et al. Molecular mechanisms of pulmonary peptidomimetic drug and peptide transport. , 2004, American journal of respiratory cell and molecular biology.
[25] Tudor I. Oprea,et al. Toward minimalistic modeling of oral drug absorption. , 1999, Journal of molecular graphics & modelling.
[26] Silvio Albertini,et al. Modulation of gene and protein expression by carbon tetrachloride in the rat liver. , 2002, Toxicology and applied pharmacology.
[27] Robert P Tonge,et al. Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[28] Yudong D. He,et al. Activators of the rat pregnane X receptor differentially modulate hepatic and intestinal gene expression. , 2004, Molecular pharmacology.
[29] Donna L Mendrick,et al. Toxicogenomics: a new revolution in drug safety. , 2002, Drug discovery today.
[30] Sean Ekins,et al. In silico ADME/Tox: the state of the art. , 2002, Journal of molecular graphics & modelling.
[31] Bryan L Roth,et al. Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discovery. , 2004, Pharmacology & therapeutics.
[32] T. Nikolskaya,et al. Algorithms for network analysis in systems-ADME/Tox using the MetaCore and MetaDrug platforms , 2006, Xenobiotica; the fate of foreign compounds in biological systems.
[33] Milton H. Saier,et al. TCDB: the Transporter Classification Database for membrane transport protein analyses and information , 2005, Nucleic Acids Res..
[34] T. Uchiumi,et al. Differential regulation of the human MRP2 and MRP3 gene expression by glucocorticoids , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[35] S. Ekins. Systems-ADME/Tox: resources and network approaches. , 2006, Journal of pharmacological and toxicological methods.
[36] M. Relling,et al. CYP1A2 and CYP2D6 4-hydroxylate propranolol and both reactions exhibit racial differences. , 2000, The Journal of pharmacology and experimental therapeutics.
[37] James W. McFarland,et al. A Novel Approach for Prediction of Intestinal Absorption of Drugs in Humans based on Hydrogen Bond Descriptors and Structural Similarity , 2001 .
[38] A. Fliri,et al. Biospectra analysis: model proteome characterizations for linking molecular structure and biological response. , 2005, Journal of medicinal chemistry.
[39] Johann Gasteiger,et al. InfVis - Platform-Independent Visual Data Mining of Multidimensional Chemical Data Sets , 2005, J. Chem. Inf. Model..
[40] Mitchell N. Cayen,et al. A guide to drug discovery: Making Better Drugs: Decision Gates in Non-Clinical Drug Development , 2003, Nature Reviews Drug Discovery.
[41] Christopher A. Lipinski,et al. Capter 11 Filtering in Drug Discovery , 2005, Annual Reports in Computational Chemistry.
[42] Sean Ekins,et al. Pathway mapping tools for analysis of high content data. , 2007, Methods in molecular biology.
[43] Takayuki Itoh,et al. Visualization of Large-Scale Aqueous Solubility Data Using a Novel Hierarchical Data Visualization Technique , 2006, J. Chem. Inf. Model..
[44] Elizabeth A. Colbourn,et al. Computers in Pharmaceutical Formulation , 2006 .
[45] K. Iseki,et al. A general approach for the prediction of the intestinal absorption of drugs: regression analysis using the physicochemical properties and drug-membrane electrostatic interaction. , 1998, Journal of pharmaceutical sciences.
[46] J L Katz,et al. 2D QSAR modeling and preliminary database searching for dopamine transporter inhibitors using genetic algorithm variable selection of Molconn Z descriptors. , 2000, Journal of medicinal chemistry.
[47] D. Cvetkovic,et al. Eigenspaces of graphs: Bibliography , 1997 .
[48] Alain Calvet,et al. Molecular Property eXplorer: A Novel Approach to Visualizing SAR Using Tree-Maps and Heatmaps , 2005, J. Chem. Inf. Model..
[49] H. Koepsell,et al. Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium. , 2005, American journal of respiratory cell and molecular biology.
[50] Kenneth M. Merz,et al. Computation of the physio‐chemical properties and data mining of large molecular collections , 2002, J. Comput. Chem..
[51] W. Pardridge,et al. Blood—Brain Barrier Genomics , 2001, Methods in molecular medicine.
[52] M C Nicklaus,et al. HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching. , 1997, Journal of medicinal chemistry.
[53] Kenneth M. Johnson,et al. Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors. , 2003, Bioorganic & medicinal chemistry letters.
[54] Pierre R. Bushel,et al. Chemical effects in biological systems (CEBS) object model for toxicology data, SysTox-OM: design and application , 2006, Bioinform..
[55] J. Sahi,et al. Metabolism and transporter-mediated drug-drug interactions of the endothelin-A receptor antagonist CI-1034. , 2006, Chemico-biological interactions.
[56] Aidong Zhang,et al. VizStruct for visualization of genome-wide SNP analyses , 2006, Bioinform..
[57] S. Ekins,et al. Progress in predicting human ADME parameters in silico. , 2000, Journal of pharmacological and toxicological methods.
[58] Stephen H. Friend,et al. Toxicogenomics and drug discovery: will new technologies help us produce better drugs? , 2002, Nature Reviews Drug Discovery.
[59] J J Baldwin,et al. Prediction of drug absorption using multivariate statistics. , 2000, Journal of medicinal chemistry.
[60] Leslie Z. Benet,et al. Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System , 2004, Pharmaceutical Research.
[61] Qutayba Hamid,et al. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. , 2003, The Journal of clinical investigation.
[62] Peter C. Jurs,et al. Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure , 1998, J. Chem. Inf. Comput. Sci..
[63] U Norinder,et al. Experimental and computational screening models for the prediction of intestinal drug absorption. , 2001, Journal of medicinal chemistry.
[64] S. Ekins,et al. Comparative Pharmacophore Modeling of Organic Anion Transporting Polypeptides: A Meta-Analysis of Rat Oatp1a1 and Human OATP1B1 , 2005, Journal of Pharmacology and Experimental Therapeutics.
[65] G. Ecker,et al. Targeting drug-efflux pumps -- a pharmacoinformatic approach. , 2005, Acta biochimica Polonica.
[66] Sean Ekins,et al. A Ligand-Based Approach to Understanding Selectivity of Nuclear Hormone Receptors PXR, CAR, FXR, LXRα, and LXRβ , 2002, Pharmaceutical Research.
[67] Akhilesh Pandey,et al. From biological databases to platforms for biomedical discovery. , 2003, Trends in biotechnology.
[68] H O Villar,et al. Protein affinity map of chemical space. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[69] M. Rothenberg,et al. Arginine in asthma and lung inflammation. , 2004, The Journal of nutrition.
[70] Yvonne C. Martin,et al. A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists , 1993, J. Comput. Aided Mol. Des..
[71] Werner J Geldenhuys,et al. Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system. , 2006, Life sciences.
[72] D. E. Clark,et al. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. , 1999, Journal of pharmaceutical sciences.
[73] S L Lin,et al. Identification of novel farnesyl protein transferase inhibitors using three-dimensional database searching methods. , 1997, Journal of medicinal chemistry.
[74] Michael D Waters,et al. Database development in toxicogenomics: issues and efforts. , 2004, Environmental health perspectives.
[75] T. Ideker,et al. Modeling cellular machinery through biological network comparison , 2006, Nature Biotechnology.
[76] D. Postma,et al. ATP-binding cassette (ABC) transporters in normal and pathological lung , 2005, Respiratory research.
[77] M F Engels,et al. Smart screening: approaches to efficient HTS. , 2001, Current opinion in drug discovery & development.
[78] E. Dougherty,et al. Unraveling gene-gene interactions regulated by ligands of the aryl hydrocarbon receptor. , 2004, Environmental health perspectives.
[79] W. L. Jorgensen. The Many Roles of Computation in Drug Discovery , 2004, Science.
[80] Sean Ekins,et al. Modeling of active transport systems. , 2002, Advanced drug delivery reviews.
[81] Han van de Waterbeemd,et al. Computer-Assisted Lead Finding and Optimization , 1997 .
[82] I. Enyedy,et al. Pharmacophore-based discovery of 3,4-disubstituted pyrrolidines as a novel class of monoamine transporter inhibitors. , 2001, Bioorganic & medicinal chemistry letters.
[83] Ahlberg. Visual exploration of HTS databases: bridging the gap between chemistry and biology. , 1999, Drug discovery today.
[84] Massimo Bertozzi,et al. Vision-based pedestrian detection: will ants help? , 2002, Intelligent Vehicle Symposium, 2002. IEEE.
[85] Ian T. Nabney,et al. Data Visualization during the Early Stages of Drug Discovery , 2006, J. Chem. Inf. Model..
[86] E. Shorter. Looking backwards: a possible new path for drug discovery in psychopharmacology , 2002, Nature Reviews Drug Discovery.
[87] Xin Chen,et al. ADME-AP: a database of ADME associated proteins , 2002, Bioinform..
[88] Charles M. Perou. Show me the data! , 2001, Nature Genetics.
[89] Gerhard Klebe,et al. AffinDB: a freely accessible database of affinities for protein–ligand complexes from the PDB , 2005, Nucleic Acids Res..
[90] A. Barabasi,et al. Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.
[91] Qing Yan,et al. Human membrane transporter database: A web-accessible relational database for drug transport studies and pharmacogenomics , 2000, AAPS PharmSci.
[92] Sean Ekins,et al. Development of Computational Models for Enzymes, Transporters, Channels, and Receptors Relevant to ADME/Tox , 2004 .
[93] Tudor I. Oprea,et al. Oncology exploration: charting cancer medicinal chemistry space. , 2006, Drug discovery today.
[94] D. Thompson,et al. Application of proteomic technologies in the drug development process. , 2003, Toxicology letters.
[95] Daniel A. Gschwend,et al. ArQiologist: An Integrated Decision Support Tool for Lead Optimization , 2005, J. Chem. Inf. Model..
[96] A. Fliri,et al. Analysis of drug-induced effect patterns to link structure and side effects of medicines , 2005, Nature chemical biology.
[97] Stephen A. Wring,et al. Passive Permeability and P-Glycoprotein-Mediated Efflux Differentiate Central Nervous System (CNS) and Non-CNS Marketed Drugs , 2002, Journal of Pharmacology and Experimental Therapeutics.
[98] Chris Orsi,et al. Integrative bioinformatics: making sense of the networks. , 2004, Drug discovery today. Technologies.
[99] Solomon Nwaka,et al. Science & society: Virtual drug discovery and development for neglected diseases through public–private partnerships , 2003, Nature Reviews Drug Discovery.
[100] R. Blakely,et al. Pharmacological profile of neuroleptics at human monoamine transporters. , 1999, European journal of pharmacology.
[101] R. Evans,et al. Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. , 2003, Molecular endocrinology.
[102] P. Meier,et al. The superfamily of organic anion transporting polypeptides. , 2003, Biochimica et biophysica acta.
[103] David M. Rocke,et al. Predicting ligand binding to proteins by affinity fingerprinting. , 1995, Chemistry & biology.
[104] Ben van Ommen,et al. Bromobenzene-induced hepatotoxicity at the transcriptome level. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[105] S. Ekins,et al. Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates. , 2002, Molecular pharmacology.
[106] N. Ozawa,et al. Transporter Database, TP-Search: A Web-Accessible Comprehensive Database for Research in Pharmacokinetics of Drugs , 2004, Pharmaceutical Research.
[107] Tomoko Niwa,et al. Using General Regression and Probabilistic Neural Networks To Predict Human Intestinal Absorption with Topological Descriptors Derived from Two-Dimensional Chemical Structures , 2003, J. Chem. Inf. Comput. Sci..
[108] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[109] A. Hopkins,et al. The druggable genome , 2002, Nature Reviews Drug Discovery.
[110] U. Norinder,et al. Computational approaches to the prediction of the blood-brain distribution. , 2002, Advanced drug delivery reviews.
[111] Sean Ekins,et al. Comprehensive computational assessment of ADME properties using mapping techniques. , 2005, Current drug discovery technologies.
[112] Charles J. Manly,et al. The impact of informatics and computational chemistry on synthesis and screening. , 2001, Drug discovery today.
[113] S. Ekins,et al. Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1. , 2003, Molecular pharmacology.
[114] D W Zaharevitz,et al. The discovery of novel, structurally diverse protein kinase C agonists through computer 3D-database pharmacophore search. Molecular modeling studies. , 1994, Journal of medicinal chemistry.
[115] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[116] Andrew Smellie,et al. Identification of Common Functional Configurations Among Molecules , 1996, J. Chem. Inf. Comput. Sci..
[117] M. Fielden,et al. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. , 2005, Journal of biotechnology.
[118] JD Tugwood,et al. Biology and toxicology of PPARg ligands , 2002 .
[119] U Norinder,et al. Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[120] Thomas Lengauer,et al. Novel technologies for virtual screening. , 2004, Drug discovery today.
[121] M. Rawlins. Cutting the cost of drug development? , 2004, Nature Reviews Drug Discovery.
[122] Samir Mitragotri,et al. Design principles of chemical penetration enhancers for transdermal drug delivery. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[123] R. Blakely,et al. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. , 1997, European journal of pharmacology.
[124] P. Lord. Progress in applying genomics in drug development. , 2003, Toxicology letters.
[125] Shayne C. Gad,et al. Drug Discovery Handbook , 1994 .
[126] Jerry Lanfear. Dealing with the data deluge , 2002, Nature Reviews Drug Discovery.
[127] Dragos Horvath,et al. Neighborhood Behavior of in Silico Structural Spaces with Respect to in Vitro Activity Spaces-A Novel Understanding of the Molecular Similarity Principle in the Context of Multiple Receptor Binding Profiles , 2003, J. Chem. Inf. Comput. Sci..
[128] S. Ekins,et al. STRUCTURAL BIOLOGY AND FUNCTION OF SOLUTE TRANSPORTERS: IMPLICATIONS FOR IDENTIFYING AND DESIGNING SUBSTRATES , 2002, Drug metabolism reviews.
[129] J. Lehmann,et al. An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway , 1998, Cell.
[130] David J Diller,et al. Fast small molecule similarity searching with multiple alignment profiles of molecules represented in one-dimension. , 2005, Journal of medicinal chemistry.
[131] Sean Ekins,et al. In vitro and pharmacophore insights into CYP3A enzymes. , 2003, Trends in pharmacological sciences.
[132] B Testa,et al. Predicting blood-brain barrier permeation from three-dimensional molecular structure. , 2000, Journal of medicinal chemistry.
[133] K. Nakata,et al. A Nuclear Receptor Database that Maps Pathways to Diseases , 2002 .
[134] G. Ecker,et al. Lead Identification for Modulators of Multidrug Resistance based on in silico Screening with a Pharmacophoric Feature Model , 2004, Archiv der Pharmazie.
[135] R. Evans,et al. A nuclear receptor-mediated xenobiotic response and its implication in drug metabolism and host protection. , 2003, Current drug metabolism.
[136] Peter W Swaan,et al. Computational approaches to modeling drug transporters. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[137] J. Kuromitsu,et al. Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator- activated receptor alpha agonists. , 2002, Biochemical and biophysical research communications.
[138] J. Klein,et al. Overview of proteomics. , 2004, Contributions to nephrology.
[139] C. Moyes,et al. 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists. , 2001, Journal of medicinal chemistry.
[140] R. Tennant,et al. Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base. , 2002 .
[141] Bruno Boulanger,et al. Towards a new age of virtual ADME/TOX and multidimensional drug discovery , 2002, J. Comput. Aided Mol. Des..
[142] P. Sprague. Automated chemical hypothesis generation and database searching with Catalyst , 1995 .
[143] Narayanan Surendran,et al. Implementation of an ADME enabling selection and visualization tool for drug discovery. , 2004, Journal of pharmaceutical sciences.
[144] L. Lesko,et al. Microarray data—the US FDA, industry and academia , 2003, Nature Biotechnology.
[145] H. Kubinyi. Drug research: myths, hype and reality , 2003, Nature Reviews Drug Discovery.
[146] R Abagyan,et al. Rational discovery of novel nuclear hormone receptor antagonists , 2000, Proc. Natl. Acad. Sci. USA.
[147] Qiong Gao,et al. pSTIING: a ‘systems’ approach towards integrating signalling pathways, interaction and transcriptional regulatory networks in inflammation and cancer , 2005, Nucleic Acids Res..